Notes / Company Aarti Drugs Ltd. AARTIDRUGS BSE 524348 ISIN INE767A01016 Pharmaceuticals Fundamentals Market cap₹3,559 cr P/E18.26× ROE12.28% Debt / equity0.45 Div yield0.51% 52-week range 318.95 — 564.05 Research on Tijori Finance The timeline — 1 note on Aarti Drugs Ltd. May 2026 23 May 26 · 11:37 PM IST Brief Brief · Earnings Aarti Drugs targets 14% EBITDA margins as new plant ramps up Management expects utilization at the Sayakha methylamine facility to hit 70% within a year, even as the salicylic acid plant remains offline. Verify on exchange BSE filings for AARTIDRUGS NSE filings for AARTIDRUGS Tijori Finance company page